To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SGPL1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
367 supporting clones for gene SGPL1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BP315083 mammary gland .a 1 to 588 6 to 593   tiling clone,   593/593
(100 %)
1 diff
(99.9 %id)
BX353997 Neuroblastoma Cot 25-normalized .a 10 to 913 1 to 904   tiling clone,   904/904
(100 %)
4 diff
(99.6 %id)
BU597239 mixed (pool of 40 RNAs) .a 25 to 823 1 to 800   tiling clone,   800/809
(98 %)
13 diff
(98.4 %id)
BX353996 Neuroblastoma Cot 25-normalized .a 1267 to 2216 947 to 1   tiling clone,   947/947
(100 %)
6 diff
(99.4 %id)
AK314615 testis .b 1 to 1837 2 to 1838 exact tiling clone,   1838/1838
(100 %)
1 diff
(100.0 %id)
DB069878 testis .b 1 to 554 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA477449   .c 1 to 572 5 to 577   capped   576/576
(100 %)
7 diff
(98.8 %id)
BP314492 mammary gland .c 1 to 581 3 to 583       583/583
(100 %)
4 diff
(99.4 %id)
BP312884 mammary gland .c 1 to 610 2 to 611   tiling clone,   611/611
(100 %)
3 diff
(99.6 %id)
DA460702 tongue, tumor tissue .c 2 to 562 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
NM_003901.3   .c 2 to 5784 1 to 5783 exact RefSeq,   5783/5783
(100 %)
0 diff
(100 %id)
BP314104 mammary gland .c 2 to 582 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP357568 mammary gland .c 2 to 584 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BP364189 lung .c 2 to 584 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA102228 cerebellum .c 3 to 590 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA619259   .c 3 to 603 2 to 602   capped   601/601
(100 %)
1 diff
(99.9 %id)
BP313306 mammary gland .c 3 to 579 1 to 577       577/583
(98 %)
6 diff
(99.0 %id)
BP357923 mammary gland .c 5 to 587 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BC052991 Skin, melanotic melanoma. .c 14 to 4703 1 to 4686 exact tiling clone, available from MGC, AAA   4686/4686
(100 %)
3 diff
(100.0 %id)
BU166412 melanotic melanoma, skin .c 16 to 819 1 to 816       816/843
(96 %)
21 diff
(97.6 %id)
BU846030 ovary, teratocarcinoma, cell line .c 18 to 927 1 to 918       918/921
(99 %)
24 diff
(97.4 %id)
AB033078 brain .c 24 to 5768 1 to 5741 exact tiling clone, available from KIAA,   5741/5741
(100 %)
3 diff
(100.0 %id)
DA804057 brain .c 63 to 604 2 to 543   capped   542/542
(100 %)
4 diff
(99.3 %id)
AJ011304   .c 113 to 2177 66 to 2131 C404A     2064/2131
(96 %)
10 diff
(99.6 %id)
BX957002   .c 173 to 927 1 to 755       752/762
(98 %)
6 diff
(99.3 %id)
AF144638   .c 224 to 1930 1 to 1707 exact     1707/1707
(100 %)
3 diff
(99.9 %id)
AA338781 brain .c 273 to 515 1 to 243       243/243
(100 %)
0 diff
(100 %id)
AW895177 nervous_normal .c 279 to 418 174 to 34       141/174
(81 %)
0 diff
(100 %id)
CD617673   .c 459 to 1025 1 to 567       567/573
(98 %)
8 diff
(98.7 %id)
CD617671   .c 460 to 1025 1 to 567       567/573
(98 %)
10 diff
(98.3 %id)
CD617672   .c 463 to 1025 568 to 6       563/572
(98 %)
2 diff
(99.7 %id)
CD617674   .c 463 to 1021 563 to 8       556/567
(98 %)
4 diff
(99.3 %id)
BF514352   .c 543 to 1067 541 to 17   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 525/541
(97 %)
1 diff
(99.9 %id)
BF310323 brain, neuroblastoma .c 636 to 1278 1 to 653       653/963
(67 %)
28 diff
(97.1 %id)
BX282607   .c 807 to 1317 1 to 511       511/511
(100 %)
0 diff
(100 %id)
CN357516 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 1187 to 1771 1 to 585       585/585
(100 %)
1 diff
(99.9 %id)
BQ311854 breast_normal .c 1201 to 1435 244 to 11       234/245
(95 %)
1 diff
(99.6 %id)
BP301213   .c 1284 to 1866 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
CV361802 marrow .c 1305 to 1699 395 to 1     Submitted on the opposite strand 395/395
(100 %)
8 diff
(98.0 %id)
AW371680 breast .c 1338 to 1595 443 to 186       258/443
(58 %)
0 diff
(100 %id)
BQ364105 stomach .c 1338 to 1516 227 to 49       179/227
(78 %)
0 diff
(100 %id)
BI047621 stomach .c 1358 to 1890 6 to 541       536/541
(99 %)
15 diff
(97.3 %id)
AL599962   .c 1405 to 1998 1 to 594       594/594
(100 %)
5 diff
(99.2 %id)
BE152613 head_neck .c 1416 to 1916 505 to 1     Submitted on the opposite strand 505/505
(100 %)
15 diff
(97.1 %id)
BF834482 head_neck .c 1470 to 1760 291 to 2     Submitted on the opposite strand 290/296
(97 %)
7 diff
(97.7 %id)
AW651710 cervical carcinoma cell line, cervix .c 1471 to 1927 1 to 457       457/457
(100 %)
3 diff
(99.4 %id)
BF809560 colon_ins .c 1518 to 1941 428 to 10     Submitted on the opposite strand 419/428
(97 %)
0 diff
(100 %id)
BQ364128 stomach .c 1522 to 1866 342 to 1       342/367
(93 %)
13 diff
(96.5 %id)
BU627688 Bone, Enchondroma cell line .c 1561 to 2242 700 to 19   AAA   682/682
(100 %)
1 diff
(99.9 %id)
DB444316 testis .c 1563 to 2024 1 to 459       459/459
(100 %)
13 diff
(97.2 %id)
T86263 liver and spleen .c 1617 to 1918 1 to 312   fully sequenced,   312/312
(100 %)
2 diff
(99.4 %id)
CA307922 Alveolar Macrophage, lung .c 1644 to 2249 624 to 19   AAA   606/606
(100 %)
0 diff
(100 %id)
AA777803 liver and spleen .c 1649 to 2177 528 to 1       528/528
(100 %)
1 diff
(99.9 %id)
BF513285   .c 1649 to 2228 597 to 18   AAA   580/580
(100 %)
0 diff
(100 %id)
DA440097 tongue, tumor tissue .c 1692 to 2292 2 to 602   capped   601/601
(100 %)
0 diff
(100 %id)
BU429821 lymph .c 1728 to 2106 8 to 386       379/396
(95 %)
7 diff
(98.3 %id)
TI_154151041   .c 1728 to 2257 80 to 609       530/531
(99 %)
7 diff
(98.7 %id)
AK023873 thyroid gland .c 1747 to 4703 1 to 2955   tiling clone, available from FLJ,   2955/2955
(100 %)
3 diff
(99.9 %id)
AU141266 thyroid gland .c 1748 to 2408 2 to 662   capped   661/661
(100 %)
0 diff
(100 %id)
AA505283 breast .c 1766 to 2176 410 to 1       410/410
(100 %)
1 diff
(99.8 %id)
TI_159679419   .c 1803 to 2529 900 to 193       708/1090
(64 %)
0 diff
(100 %id)
TI_159687963   .c 1803 to 2529 928 to 212       717/1103
(65 %)
0 diff
(100 %id)
BF094286 uterus_tumor .c 1817 to 2061 260 to 16       245/260
(94 %)
0 diff
(100 %id)
BX505783   .c 1871 to 2411 1 to 541       541/541
(100 %)
0 diff
(100 %id)
T86156 liver and spleen .c 1888 to 2184 306 to 1   fully sequenced,   306/306
(100 %)
8 diff
(97.4 %id)
CD654698 Embryonic Stem cells .c 1969 to 2763 4 to 791       788/809
(97 %)
6 diff
(99.3 %id)
AU126181   .c 1979 to 2374 2 to 397   capped   396/396
(100 %)
3 diff
(99.3 %id)
DA688508   .c 2009 to 2466 2 to 458   capped   457/457
(100 %)
3 diff
(99.4 %id)
AU130536   .c 2014 to 2614 2 to 604   capped   603/603
(100 %)
2 diff
(99.7 %id)
BF917997 uterus_tumor .c 2038 to 2534 502 to 1     Submitted on the opposite strand 502/511
(98 %)
10 diff
(98.1 %id)
BE833558 ovary .c 2049 to 2370 326 to 5       322/345
(93 %)
0 diff
(100 %id)
AA112743   .c 2070 to 2469 1 to 402       402/402
(100 %)
3 diff
(99.3 %id)
DB240731 trachea .c 2117 to 2702 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DA751475   .c 2304 to 2787 2 to 484   capped   483/483
(100 %)
1 diff
(99.8 %id)
DA903655   .c 2403 to 2909 2 to 508   capped   507/507
(100 %)
2 diff
(99.7 %id)
BQ774696 Bone, Human Chondrosarcoma Cell Line .c 2410 to 3137 1 to 725     Submitted on the opposite strand 725/725
(100 %)
4 diff
(99.5 %id)
CN357519 embryonic stem cells, cell lines H1, H7, andH9 .c 2418 to 2866 1 to 449       449/449
(100 %)
5 diff
(98.9 %id)
AA488551   .c 2426 to 2742 1 to 316       316/316
(100 %)
4 diff
(98.8 %id)
AI999817   .c 2430 to 2898 1 to 477       477/477
(100 %)
15 diff
(96.9 %id)
BQ224779 large cell carcinoma, lung .c 2477 to 3347 1 to 880       880/885
(99 %)
15 diff
(98.4 %id)
BQ224066 melanotic melanoma, skin .c 2493 to 3329 1 to 839       839/839
(100 %)
11 diff
(98.7 %id)
DA982527 synovial membrane tissue from rheumatioidarthritis .c 2508 to 3075 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA465156   .c 2509 to 3080 2 to 574   capped   573/574
(99 %)
2 diff
(99.7 %id)
CB157865 Liver .c 2527 to 2882 1 to 356       356/356
(100 %)
1 diff
(99.8 %id)
AI279756 2 pooled tumors (clear cell type), Kidney .c 2593 to 2937 1 to 345     Submitted on the opposite strand 345/345
(100 %)
2 diff
(99.5 %id)
DA283892 corpus callosum .c 2600 to 3176 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
CN357512 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 2602 to 2808 1 to 207       207/207
(100 %)
4 diff
(98.1 %id)
CN357514 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 2606 to 2810 1 to 205       205/205
(100 %)
0 diff
(100 %id)
DA429697 colon .c 2632 to 3191 2 to 561   capped   560/563
(99 %)
1 diff
(99.9 %id)
DA046757   .c 2664 to 3532 2 to 869   capped   868/868
(100 %)
10 diff
(98.9 %id)
CN357515 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 2672 to 3307 6 to 641       636/641
(99 %)
6 diff
(99.1 %id)
DB193980 ovary, tumor tissue .c 2719 to 3287 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
AA056402 colon, tumor .c 2747 to 2891 1 to 148     Submitted on the opposite strand 148/157
(94 %)
4 diff
(97.5 %id)
BQ933085 large cell carcinoma, lung .c 2778 to 3680 1 to 907       907/910
(99 %)
26 diff
(97.2 %id)
DA281314 corpus callosum .c 2782 to 3272 2 to 492   capped   491/491
(100 %)
5 diff
(99.0 %id)
BM556374 duodenal adenocarcinoma, cell line, small intestine .c 2800 to 3757 1 to 963       963/1033
(93 %)
21 diff
(98.0 %id)
DA795077 brain .c 2820 to 3333 2 to 516   capped   515/515
(100 %)
3 diff
(99.5 %id)
AU133910 ovary, tumor tissue .c 2822 to 3551 2 to 734   capped   733/735
(99 %)
17 diff
(97.7 %id)
DA025020   .c 2840 to 3424 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
CB214990 normal endometrium, late proliferativephase, cycle day 13, uterus .c 2842 to 3424 1 to 583       583/583
(100 %)
0 diff
(100 %id)
AI525871 Prostate .c 2859 to 3325 8 to 475       468/861
(54 %)
6 diff
(99.4 %id)
BF033245 adenocarcinoma, ovary .c 2954 to 3612 1 to 658       658/659
(99 %)
12 diff
(98.2 %id)
CA431700 Bone, Subchondral Bone .c 2967 to 3395 1 to 428     Submitted on the opposite strand 428/428
(100 %)
3 diff
(99.3 %id)
DA026833   .c 2968 to 3532 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
BQ356067 head_neck .c 3067 to 3388 1 to 323       323/323
(100 %)
2 diff
(99.4 %id)
BF034224 adenocarcinoma, ovary .c 3085 to 3715 1 to 635       635/635
(100 %)
8 diff
(98.8 %id)
BG118869 adenocarcinoma, cell line, Liver .c 3098 to 3836 1 to 745       745/783
(95 %)
20 diff
(97.5 %id)
DB105154 thymus .c 3157 to 3712 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
BX483235   .c 3204 to 3729 1 to 527       527/527
(100 %)
2 diff
(99.7 %id)
BM464606 lymph, lymphoma, cell line .c 3204 to 4045 25 to 865       841/1153
(72 %)
6 diff
(99.5 %id)
BG402973 bladder, transitional cell papilloma, cell line .c 3214 to 3962 1 to 744       744/951
(78 %)
16 diff
(98.4 %id)
AU118779 whole embryo, mainly head .c 3215 to 3984 2 to 770   capped   769/769
(100 %)
4 diff
(99.5 %id)
BX499484 Liver .c 3216 to 3656 1 to 441       441/441
(100 %)
0 diff
(100 %id)
AW967204   .c 3232 to 3871 11 to 649       639/649
(98 %)
6 diff
(99.1 %id)
Z45630 brain, total brain .c 3232 to 3531 1 to 300       300/300
(100 %)
1 diff
(99.7 %id)
R12199 whole brain .c 3232 to 3563 1 to 342       342/345
(99 %)
17 diff
(95.1 %id)
BY995565   .c 3232 to 3922 22 to 712       691/712
(97 %)
6 diff
(99.2 %id)
T08353   .c 3233 to 3610 1 to 378       378/378
(100 %)
0 diff
(100 %id)
CB120550 Liver .c 3233 to 3672 1 to 440       440/440
(100 %)
1 diff
(99.8 %id)
BG577243 breast, mammary adenocarcinoma, cell line .c 3247 to 3927 1 to 681       681/683
(99 %)
2 diff
(99.8 %id)
BG697066 skin .c 3305 to 4091 1 to 781       781/781
(100 %)
5 diff
(99.4 %id)
BG697152 skin .c 3306 to 4098 1 to 785       785/786
(99 %)
12 diff
(98.5 %id)
FN136948 breast carcinoma .c 3343 to 3398 55 to 1     Submitted on the opposite strand 55/56
(98 %)
1 diff
(98.3 %id)
EY198495 intestinal (Lauren) gastric adenocarcinoma, stomach .c 3373 to 3726 352 to 1     Submitted on the opposite strand 352/370
(95 %)
5 diff
(98.7 %id)
BF734364 amnion_normal .c 3389 to 3905 17 to 534       518/560
(92 %)
26 diff
(95.4 %id)
BE616895 adenocarcinoma, Pancreas .c 3403 to 4225 3 to 831       829/911
(90 %)
6 diff
(99.4 %id)
AW964308   .c 3418 to 3834 1 to 427       427/445
(95 %)
55 diff
(87.7 %id)
BE614760 adenocarcinoma, Pancreas .c 3421 to 4211 1 to 790       790/1120
(70 %)
27 diff
(97.6 %id)
BE531109 adenocarcinoma, Pancreas .c 3422 to 4188 1 to 765       765/963
(79 %)
15 diff
(98.5 %id)
BE615007 adenocarcinoma, Pancreas .c 3422 to 4208 1 to 783       783/784
(99 %)
21 diff
(97.4 %id)
BE615254 adenocarcinoma, Pancreas .c 3422 to 4091 1 to 675       675/1175
(57 %)
22 diff
(98.2 %id)
BU508859 leiomyosarcoma, uterus .c 3423 to 4263 1 to 848       848/934
(90 %)
19 diff
(98.0 %id)
AW403351 lymph .c 3444 to 3873 1 to 430       430/430
(100 %)
5 diff
(98.9 %id)
TI_154139998   .c 3451 to 3939 80 to 570       491/651
(75 %)
3 diff
(99.6 %id)
TI_154143049   .c 3451 to 4187 82 to 811       730/731
(99 %)
51 diff
(93.1 %id)
BE873557 adenocarcinoma, colon .c 3507 to 4311 1 to 801       801/859
(93 %)
43 diff
(95.0 %id)
BF036983 adenocarcinoma, ovary .c 3516 to 4226 1 to 709       709/709
(100 %)
6 diff
(99.2 %id)
BQ069499 brain, neuroblastoma, cell line .c 3558 to 4368 1 to 827       827/1112
(74 %)
41 diff
(96.4 %id)
BX092232   .c 3580 to 4249 1 to 668       668/668
(100 %)
1 diff
(99.9 %id)
AA436097   .c 3580 to 4127 1 to 542       542/542
(100 %)
5 diff
(99.1 %id)
AW874245 tumor, uterus .c 3610 to 3991 456 to 75       382/456
(83 %)
0 diff
(100 %id)
BQ377586 uterus .c 3618 to 4075 19 to 473       455/476
(95 %)
7 diff
(98.6 %id)
AA279048 germinal center B cell .c 3618 to 4174 1 to 551       551/552
(99 %)
6 diff
(99.0 %id)
DA600330   .c 3629 to 4172 2 to 540   capped   539/539
(100 %)
3 diff
(99.5 %id)
BI005568 head_normal .c 3665 to 3994 12 to 344       333/344
(96 %)
19 diff
(94.5 %id)
BC041567 Eye, retinoblastoma .c 3690 to 5768 1 to 2077   available from MGC, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 2077/2077
(100 %)
2 diff
(100.0 %id)
BE253023 eye, retinoblastoma .c 3709 to 4292 1 to 581   available from MGC,   581/581
(100 %)
10 diff
(98.3 %id)
BE545647 cervical carcinoma cell line, cervix .c 3715 to 4384 1 to 668       668/827
(80 %)
27 diff
(96.8 %id)
CK570293 rectum .c 3727 to 3914 188 to 1       188/188
(100 %)
1 diff
(99.5 %id)
CB119723 Liver .c 3727 to 4164 1 to 436       436/436
(100 %)
2 diff
(99.6 %id)
AA292520 ovarian tumor, ovary .c 3728 to 4092 1 to 364       364/364
(100 %)
3 diff
(99.2 %id)
DB187055 liver, tumor tissue .c 3736 to 4309 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
FN081262 breast carcinoma .c 3741 to 3840 98 to 1     Submitted on the opposite strand 98/99
(98 %)
2 diff
(98.0 %id)
DA028659   .c 3752 to 4329 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
BM725194 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 3785 to 4054 1 to 268   fully sequenced,   268/268
(100 %)
1 diff
(99.7 %id)
EL594798 epidermis, skin .c 3791 to 4315 524 to 1     Submitted on the opposite strand 524/537
(97 %)
4 diff
(99.3 %id)
AW868670 stomach_normal .c 3820 to 4271 460 to 5       456/472
(96 %)
0 diff
(100 %id)
AW889749 nervous_tumor .c 3823 to 4150 350 to 27       324/356
(91 %)
0 diff
(100 %id)
BG986964 head_neck .c 3823 to 4152 10 to 333       324/336
(96 %)
12 diff
(96.5 %id)
BE170816 head_neck .c 3826 to 4162 344 to 10     Submitted on the opposite strand 335/350
(95 %)
0 diff
(100 %id)
BG986781 head_neck .c 3830 to 4148 320 to 4       317/320
(99 %)
0 diff
(100 %id)
BC031338 Uterus, endometrium adenocarcinoma .c 3849 to 4578 1 to 728   available from MGC, AAA   728/728
(100 %)
1 diff
(99.9 %id)
BE393837 endometrium, adenocarcinoma cell line, uterus .c 3868 to 4420 1 to 550   available from MGC,   550/550
(100 %)
6 diff
(99.0 %id)
BG121383 adenocarcinoma, cell line, Liver .c 3891 to 4581 1 to 692       692/932
(74 %)
32 diff
(96.6 %id)
AI375141 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 3905 to 4359 466 to 14   AAA   453/453
(100 %)
1 diff
(99.8 %id)
BG577401   .c 3915 to 4495 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
BQ776380 Pancreas, Purified pancreatic islet .c 3930 to 4528 10 to 605       596/605
(98 %)
6 diff
(99.1 %id)
BU622668 cell lines, Chondrosarcoma .c 3938 to 4697 776 to 19   AAA   758/758
(100 %)
6 diff
(99.3 %id)
AW380781 head_neck .c 3940 to 4175 15 to 247       233/247
(94 %)
6 diff
(97.6 %id)
BE741588 adenocarcinoma cell line, ovary .c 3944 to 4722 1 to 776       776/780
(99 %)
17 diff
(97.9 %id)
TI_151724492   .c 3985 to 4697 795 to 82   AAA   714/958
(74 %)
4 diff
(99.6 %id)
CA424723 cell lines, Chondrosarcoma .c 3991 to 4578 606 to 19   tiling clone, AAA   588/640
(91 %)
0 diff
(100 %id)
CA309241 Alveolar Macrophage, lung .c 4016 to 4703 707 to 19   AAA   689/689
(100 %)
4 diff
(99.5 %id)
BE076028 breast .c 4018 to 4278 1 to 260       260/260
(100 %)
8 diff
(97.0 %id)
BU626117 cell lines, Enchondroma .c 4021 to 4703 702 to 19   AAA   684/684
(100 %)
1 diff
(99.9 %id)
BF755244 colon .c 4023 to 4276 38 to 290       253/293
(86 %)
12 diff
(96.0 %id)
BM678208 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 4024 to 4703 698 to 19   fully sequenced, AAA   680/680
(100 %)
0 diff
(100 %id)
BE075662 breast .c 4026 to 4413 387 to 1     Submitted on the opposite strand 387/387
(100 %)
4 diff
(99.0 %id)
R61621 whole brain .c 4035 to 4492 1 to 458       458/461
(99 %)
6 diff
(98.7 %id)
AW673171 cervical carcinoma cell line, cervix .c 4036 to 4556 521 to 1       521/521
(100 %)
1 diff
(99.9 %id)
BM794465 Ascites, stomach .c 4041 to 4659 1 to 619       619/619
(100 %)
0 diff
(100 %id)
CA427958 Bone, Subchondral Bone .c 4042 to 4697 674 to 19   AAA   656/658
(99 %)
6 diff
(99.1 %id)
AL601292   .c 4050 to 4506 1 to 457       457/457
(100 %)
10 diff
(97.9 %id)
FN136192 breast carcinoma .c 4058 to 4140 80 to 1     Submitted on the opposite strand 80/80
(100 %)
4 diff
(95.0 %id)
AA248103   .c 4064 to 4250 1 to 182       182/182
(100 %)
7 diff
(96.2 %id)
TI_154132106   .c 4070 to 4703 755 to 121   AAA   635/764
(83 %)
5 diff
(99.4 %id)
BE181342 head_neck .c 4085 to 4421 1 to 337       337/351
(96 %)
7 diff
(98.1 %id)
W37975 parathyroid gland, parathyroid tumor .c 4086 to 4676 1 to 592       592/592
(100 %)
7 diff
(98.9 %id)
DB371511 ovary, tumor tissue .c 4109 to 4694 587 to 1       587/591
(99 %)
22 diff
(96.3 %id)
AU145264 whole embryo, mainly head .c 4120 to 4697 571 to 1       571/578
(98 %)
12 diff
(98.0 %id)
N77080 liver and spleen .c 4121 to 4315 1 to 199   fully sequenced,   199/199
(100 %)
1 diff
(99.5 %id)
BF798104 colon_ins .c 4122 to 4442 1 to 317       317/321
(98 %)
16 diff
(95.1 %id)
CD693101 normal nasopharynx .c 4127 to 4403 5 to 281       277/281
(98 %)
6 diff
(97.9 %id)
BQ326896 colon_normal .c 4142 to 4248 122 to 15       108/122
(88 %)
0 diff
(100 %id)
H48697 liver and spleen .c 4149 to 4542 9 to 407       399/416
(95 %)
6 diff
(98.6 %id)
AW574730 lymph .c 4153 to 4703 568 to 18   AAA   551/551
(100 %)
0 diff
(100 %id)
AI091626 parathyroid gland, parathyroid tumor .c 4166 to 4703 552 to 15   AAA   538/538
(100 %)
0 diff
(100 %id)
AI916310 carcinoid, lung .c 4167 to 4704 538 to 1       538/538
(100 %)
1 diff
(99.9 %id)
AW612685 carcinoid, lung .c 4167 to 4699 534 to 2       533/534
(99 %)
0 diff
(100 %id)
AU152452   .c 4174 to 4703 531 to 1       531/543
(97 %)
15 diff
(97.3 %id)
BF879976 lung_tumor .c 4180 to 4326 28 to 175       148/175
(84 %)
11 diff
(93.8 %id)
AI469657 colon, moderately-differentiated adenocarcinoma .c 4187 to 4581 395 to 1       395/395
(100 %)
3 diff
(99.3 %id)
BP393721 pancreatic islet .c 4199 to 4703 1 to 505     Submitted on the opposite strand 505/505
(100 %)
1 diff
(99.9 %id)
AA319601 adrenal gland .c 4200 to 4505 1 to 306       306/306
(100 %)
1 diff
(99.7 %id)
R84511 liver and spleen .c 4200 to 4350 1 to 151       151/151
(100 %)
0 diff
(100 %id)
BP392064 pancreatic islet .c 4205 to 4703 1 to 500     Submitted on the opposite strand 500/500
(100 %)
2 diff
(99.6 %id)
AI042014 parathyroid gland, parathyroid tumor .c 4205 to 4703 513 to 15   AAA   499/499
(100 %)
0 diff
(100 %id)
AI739573 colon, colon tumor, RER+ .c 4205 to 4697 511 to 19   AAA   493/493
(100 %)
0 diff
(100 %id)
BQ355675 head_neck .c 4215 to 4620 430 to 25       406/430
(94 %)
0 diff
(100 %id)
CV573309 cornea, eye .c 4221 to 4824 1 to 604       604/604
(100 %)
1 diff
(99.9 %id)
AU158877 thyroid gland .c 4234 to 4703 469 to 1       469/469
(100 %)
27 diff
(94.3 %id)
AA609532   .c 4237 to 4699 467 to 5       463/467
(99 %)
0 diff
(100 %id)
BP386756 pancreatic islet .c 4245 to 4705 1 to 461     Submitted on the opposite strand 461/464
(99 %)
2 diff
(99.6 %id)
AI797018 carcinoid, lung .c 4246 to 4693 449 to 1       449/449
(100 %)
2 diff
(99.6 %id)
AA932058 carcinoid, lung .c 4249 to 4699 452 to 2       451/452
(99 %)
0 diff
(100 %id)
AI276771 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 4250 to 4698 449 to 1       449/449
(100 %)
1 diff
(99.8 %id)
BE181358 head_neck .c 4251 to 4577 329 to 3     Submitted on the opposite strand 327/329
(99 %)
0 diff
(100 %id)
AA278274 germinal center B cell .c 4251 to 4699 455 to 7       449/455
(98 %)
0 diff
(100 %id)
AW014173   .c 4253 to 4703 468 to 18   AAA   451/461
(97 %)
1 diff
(99.8 %id)
AI678983 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 4261 to 4697 437 to 1       437/437
(100 %)
0 diff
(100 %id)
AI827194 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 4262 to 4703 442 to 1       442/442
(100 %)
1 diff
(99.8 %id)
DA615019   .c 4264 to 4834 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
CN357517 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 4270 to 4697 1 to 428   AAA   428/428
(100 %)
1 diff
(99.8 %id)
CN357510 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 4272 to 4669 1 to 398       398/398
(100 %)
0 diff
(100 %id)
AA435998   .c 4273 to 4699 431 to 5       427/431
(99 %)
0 diff
(100 %id)
BE181359 head_neck .c 4278 to 4556 289 to 2     Submitted on the opposite strand 288/289
(99 %)
0 diff
(100 %id)
AI185869 lung .c 4278 to 4704 427 to 1       427/427
(100 %)
2 diff
(99.6 %id)
AW173602 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 4283 to 4697 415 to 1       415/415
(100 %)
0 diff
(100 %id)
AW607555 head_neck .c 4285 to 4653 1 to 371       371/373
(99 %)
19 diff
(95.0 %id)
N59392 liver and spleen .c 4285 to 4698 414 to 1   fully sequenced,   414/414
(100 %)
0 diff
(100 %id)
AI674300 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 4285 to 4704 420 to 1       420/420
(100 %)
1 diff
(99.8 %id)
FN111215 breast carcinoma .c 4288 to 4407 120 to 1     Submitted on the opposite strand 120/120
(100 %)
0 diff
(100 %id)
AA699330 liver and spleen .c 4289 to 4698 410 to 1       410/410
(100 %)
0 diff
(100 %id)
CN357513 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 4295 to 4948 1 to 654       654/657
(99 %)
4 diff
(99.4 %id)
AA235660 ovarian tumor, ovary .c 4297 to 4703 407 to 1       407/407
(100 %)
0 diff
(100 %id)
AA846834 parathyroid gland, parathyroid tumor .c 4298 to 4701 420 to 17       404/420
(96 %)
0 diff
(100 %id)
BQ356068 head_neck .c 4299 to 4620 346 to 27       320/346
(92 %)
0 diff
(100 %id)
AA343823 gall bladder .c 4302 to 4592 1 to 291       291/291
(100 %)
1 diff
(99.7 %id)
AI674293 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 4309 to 4705 402 to 6       397/402
(98 %)
0 diff
(100 %id)
AA480668 colon .c 4313 to 4704 392 to 1       392/392
(100 %)
1 diff
(99.8 %id)
AW273244 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 4314 to 4703 400 to 11   AAA   390/390
(100 %)
0 diff
(100 %id)
BG998108 head_neck .c 4327 to 4459 147 to 14       134/147
(91 %)
0 diff
(100 %id)
AI301617 carcinoid, lung .c 4330 to 4702 373 to 1       373/373
(100 %)
0 diff
(100 %id)
BE327337 carcinoid, lung .c 4330 to 4705 378 to 3       376/378
(99 %)
0 diff
(100 %id)
BG055831 anaplastic oligodendroglioma, brain .c 4336 to 4705 372 to 3       370/372
(99 %)
0 diff
(100 %id)
AW236398 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 4337 to 4705 370 to 2       369/370
(99 %)
0 diff
(100 %id)
BI868379 adenocarcinoma, cell line, Liver .c 4337 to 5094 1 to 760       760/760
(100 %)
3 diff
(99.7 %id)
TI_57228036   .c 4337 to 5094 51 to 810       760/760
(100 %)
3 diff
(99.7 %id)
AI251011 adenocarcinoma, Pancreas .c 4349 to 4703 364 to 11   AAA   354/354
(100 %)
2 diff
(99.5 %id)
N53636 multiple sclerosis lesions .c 4365 to 4498 1 to 133       133/145
(91 %)
4 diff
(97.3 %id)
BE139630 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 4370 to 4697 338 to 11   AAA   328/328
(100 %)
0 diff
(100 %id)
BX371476 Neuroblastoma Cot 50-normalized .c 4374 to 5315 943 to 1       943/944
(99 %)
23 diff
(97.6 %id)
GD149945   .c 4375 to 4457 82 to 1     Submitted on the opposite strand 82/90
(91 %)
2 diff
(97.8 %id)
BG403243 bladder, transitional cell papilloma, cell line .c 4388 to 5084 1 to 693       693/693
(100 %)
7 diff
(99.0 %id)
BE181341 head_neck .c 4389 to 4607 219 to 1     Submitted on the opposite strand 219/310
(70 %)
2 diff
(99.4 %id)
DB509187 testis .c 4389 to 4696 1 to 314     Submitted on the opposite strand 314/315
(99 %)
8 diff
(97.5 %id)
AW377509 colon .c 4394 to 4613 233 to 14       220/234
(94 %)
0 diff
(100 %id)
R39923 whole brain .c 4394 to 4703 320 to 11   AAA   310/310
(100 %)
1 diff
(99.7 %id)
BF434752 Kidney .c 4408 to 4697 290 to 1       290/290
(100 %)
1 diff
(99.7 %id)
AA056528 colon, tumor .c 4410 to 4704 297 to 1     Submitted on the opposite strand 297/298
(99 %)
2 diff
(99.4 %id)
CN357511 embryonic stem cells, cell lines H1, H7, andH9 .c 4441 to 5077 1 to 637       637/637
(100 %)
2 diff
(99.7 %id)
BY798139 eye .c 4525 to 5126 1 to 602       602/602
(100 %)
1 diff
(99.9 %id)
BM761452 lymph node, stomach .c 4595 to 5097 1 to 503       503/503
(100 %)
1 diff
(99.9 %id)
BM831612 lymph node, stomach .c 4596 to 5129 1 to 533       533/533
(100 %)
3 diff
(99.5 %id)
BM697313 eye, lens .c 4599 to 5283 1 to 684       684/684
(100 %)
2 diff
(99.8 %id)
BM844375 lymph node, stomach .c 4604 to 4975 1 to 368       368/368
(100 %)
6 diff
(98.4 %id)
EC476162 Prostate .c 4606 to 4721 1 to 116       116/116
(100 %)
1 diff
(99.2 %id)
BM844566 lymph node, stomach .c 4608 to 5116 1 to 509       509/509
(100 %)
3 diff
(99.5 %id)
W05472 lung .c 4614 to 5093 1 to 470       470/470
(100 %)
12 diff
(97.5 %id)
CB217150 normal endometrium, mid-secretory phase,cycle day 23, uterus .c 4631 to 5269 1 to 639       639/639
(100 %)
1 diff
(99.9 %id)
BG291641 bladder, transitional cell papilloma, cell line .c 4633 to 5383 1 to 736       736/842
(87 %)
22 diff
(97.4 %id)
W68186 heart .c 4648 to 5212 1 to 558   fully sequenced,   558/558
(100 %)
1 diff
(99.9 %id)
BI005356 head_normal .c 4670 to 5106 439 to 2       438/439
(99 %)
0 diff
(100 %id)
BF344558 brain, glioblastoma with EGFR amplification .c 4685 to 5410 1 to 709       709/924
(76 %)
21 diff
(97.8 %id)
CN357518 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 4695 to 5244 10 to 560       551/560
(98 %)
6 diff
(99.0 %id)
CB051228 Prostate .c 4717 to 4863 10 to 156     Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 147/156
(94 %)
6 diff
(96.2 %id)
BU942508 mixed (pool of 40 RNAs) .c 4728 to 5469 1 to 745       745/775
(96 %)
7 diff
(99.1 %id)
BF921069 nervous_tumor .c 4759 to 5388 11 to 637       627/637
(98 %)
6 diff
(99.1 %id)
BM055148 Islets of Langerhans, Pancreas .c 4795 to 5359 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
CK904812 Islets of Langerhans, Pancreas .c 4795 to 5391 1 to 597       597/597
(100 %)
1 diff
(99.9 %id)
AI557050 Prostate .c 4870 to 5400 52 to 594     Submitted on the opposite strand 543/1000
(54 %)
35 diff
(96.5 %id)
BM955767 tonsil .c 4941 to 5391 44 to 492       449/492
(91 %)
6 diff
(98.8 %id)
H61835 ovarian tumor, ovary .c 4949 to 5352 1 to 409       409/409
(100 %)
5 diff
(98.8 %id)
AA442998 ovarian tumor, ovary .c 4949 to 5022 1 to 74       74/74
(100 %)
0 diff
(100 %id)
TI_149300612   .c 4998 to 5768 855 to 97   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 759/922
(82 %)
17 diff
(98.2 %id)
BF753311 colon .c 5011 to 5167 18 to 174       157/174
(90 %)
6 diff
(96.6 %id)
R77986 placenta .c 5024 to 5384 1 to 367       367/371
(98 %)
7 diff
(98.2 %id)
BX355407 Neuroblastoma Cot 50-normalized .c 5028 to 5735 708 to 1       708/853
(83 %)
69 diff
(92.0 %id)
CA432251 cell lines, Enchondroma .c 5035 to 5768 747 to 20   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 728/729
(99 %)
8 diff
(99.0 %id)
FN094282 breast carcinoma .c 5041 to 5143 1 to 102       102/102
(100 %)
1 diff
(99.1 %id)
DR155480 human embryonic stem cells differentiated toan early endodermal cell type .c 5051 to 5774 724 to 1     Submitted on the opposite strand 724/724
(100 %)
1 diff
(99.9 %id)
BQ776205 Bone, Human Chondrosarcoma Cell Line .c 5063 to 5784 719 to 3   tiling clone,   717/719
(99 %)
0 diff
(100 %id)
AW364619 denis_drash .c 5071 to 5487 614 to 198       417/614
(67 %)
0 diff
(100 %id)
BU608120 Human Lung Epithelial cells, lung .c 5091 to 5768 696 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 678/678
(100 %)
0 diff
(100 %id)
BM976649 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 5097 to 5768 688 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 670/670
(100 %)
2 diff
(99.8 %id)
AA130298 uterus .c 5123 to 5553 1 to 434       434/434
(100 %)
9 diff
(98.0 %id)
BQ953703 sciatic nerve .c 5136 to 5767 1 to 632       632/637
(99 %)
1 diff
(99.9 %id)
CD103021 Pooled-Skin .c 5141 to 5766 1 to 630       630/635
(99 %)
6 diff
(99.1 %id)
AA744773 germinal center B cell .c 5179 to 5768 625 to 37   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 589/589
(100 %)
1 diff
(99.9 %id)
W67994 heart .c 5182 to 5776 584 to 1   fully sequenced,   584/584
(100 %)
10 diff
(98.3 %id)
CK904811 Islets of Langerhans, Pancreas .c 5184 to 5782 599 to 1       599/599
(100 %)
1 diff
(99.9 %id)
BQ778468 Pancreas, Purified pancreatic islet .c 5194 to 5780 587 to 1       587/587
(100 %)
0 diff
(100 %id)
BP385501 pancreatic islet .c 5201 to 5773 1 to 574     Submitted on the opposite strand 574/574
(100 %)
1 diff
(99.9 %id)
BI253944 cervical carcinoma cell line, cervix .c 5201 to 5576 1 to 376       376/376
(100 %)
0 diff
(100 %id)
CB053543 leiomyosarcoma, soft tissue .c 5203 to 5767 10 to 574   fully sequenced, Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 565/574
(98 %)
6 diff
(99.0 %id)
AA046574 uterus .c 5210 to 5503 1 to 296   fully sequenced,   296/296
(100 %)
3 diff
(99.0 %id)
AI859149 anaplastic oligodendroglioma, brain .c 5214 to 5768 568 to 13   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 556/556
(100 %)
1 diff
(99.9 %id)
BE620867 large cell carcinoma, undifferentiated, lung .c 5222 to 5731 515 to 3       513/516
(99 %)
0 diff
(100 %id)
BM054912 Islets of Langerhans, Pancreas .c 5223 to 5782 560 to 1       560/560
(100 %)
5 diff
(99.2 %id)
CB853733 Human Lung Epithelial cells, lung .c 5227 to 5768 561 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 543/543
(100 %)
10 diff
(98.2 %id)
AI656172 pooled germ cell tumors .c 5233 to 5768 548 to 13   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 536/536
(100 %)
0 diff
(100 %id)
TI_149280312   .c 5238 to 5768 625 to 95   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 531/1122
(47 %)
24 diff
(97.9 %id)
AW149123 Kidney, renal cell tumor .c 5242 to 5769 528 to 1       528/528
(100 %)
0 diff
(100 %id)
AW261827 brain, three pooled meningiomas .c 5246 to 5779 536 to 3       534/536
(99 %)
0 diff
(100 %id)
AI636551 pooled germ cell tumors .c 5249 to 5768 520 to 1       520/520
(100 %)
0 diff
(100 %id)
AI767378 2 pooled tumors (clear cell type), Kidney .c 5267 to 5761 495 to 1       495/495
(100 %)
0 diff
(100 %id)
CB051227 Prostate .c 5267 to 5766 547 to 43   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 505/508
(99 %)
0 diff
(100 %id)
BX486770   .c 5281 to 5792 534 to 23     Submitted on the opposite strand 512/534
(95 %)
0 diff
(100 %id)
AI613091 Kidney .c 5289 to 5772 484 to 1       484/484
(100 %)
0 diff
(100 %id)
AW590529 pooled germ cell tumors .c 5296 to 5779 484 to 1       484/484
(100 %)
1 diff
(99.8 %id)
BM703055 eye, human retina .c 5296 to 5768 1 to 473   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 473/473
(100 %)
0 diff
(100 %id)
N71111 lung .c 5299 to 5768 472 to 1       472/472
(100 %)
3 diff
(99.4 %id)
N51491 multiple sclerosis lesions .c 5305 to 5780 488 to 1       488/490
(99 %)
12 diff
(97.6 %id)
AW590282 pooled germ cell tumors .c 5309 to 5780 472 to 1       472/472
(100 %)
0 diff
(100 %id)
AA134115 uterus .c 5322 to 5784 465 to 1       465/465
(100 %)
3 diff
(99.4 %id)
AW148814 brain, tumor, 5 pooled (see description) .c 5328 to 5772 445 to 1       445/445
(100 %)
0 diff
(100 %id)
H61836 ovarian tumor, ovary .c 5361 to 5765 411 to 1       411/411
(100 %)
8 diff
(98.1 %id)
AI301525 2 pooled tumors (clear cell type), Kidney .c 5361 to 5784 427 to 4       424/427
(99 %)
0 diff
(100 %id)
AI633968 Kidney .c 5364 to 5780 417 to 1       417/417
(100 %)
0 diff
(100 %id)
AA722572 heart .c 5370 to 5784 416 to 2       415/416
(99 %)
0 diff
(100 %id)
Z36854   .c 5389 to 5768 1 to 379       379/380
(99 %)
2 diff
(99.5 %id)
BM955766 tonsil .c 5392 to 5597 1 to 206       206/206
(100 %)
0 diff
(100 %id)
AW015779   .c 5392 to 5768 394 to 18   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 377/377
(100 %)
2 diff
(99.5 %id)
BE620331 large cell carcinoma, undifferentiated, lung .c 5396 to 5524 629 to 757       721/806
(89 %)
27 diff
(96.7 %id)
AI301639 2 pooled tumors (clear cell type), Kidney .c 5407 to 5768 379 to 18   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 362/362
(100 %)
0 diff
(100 %id)
R77891 placenta .c 5416 to 5755 347 to 1       347/390
(88 %)
9 diff
(97.7 %id)
AI871067 anaplastic oligodendroglioma, brain .c 5424 to 5788 366 to 2       365/366
(99 %)
0 diff
(100 %id)
AA458506 ovarian tumor, ovary .c 5425 to 5780 356 to 1       356/356
(100 %)
0 diff
(100 %id)
AA459607 ovarian tumor, ovary .c 5429 to 5769 13 to 353       341/353
(96 %)
6 diff
(98.4 %id)
AI985328 Kidney .c 5432 to 5768 337 to 1       337/337
(100 %)
1 diff
(99.8 %id)
AA862531 Kidney .c 5441 to 5772 332 to 1       332/332
(100 %)
1 diff
(99.7 %id)
BG403896 bladder, transitional cell papilloma, cell line .c 5443 to 5768 1 to 320   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 320/320
(100 %)
6 diff
(98.2 %id)
CB053542 leiomyosarcoma, soft tissue .c 5466 to 5780 349 to 35   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 315/315
(100 %)
2 diff
(99.4 %id)
AA046661 uterus .c 5473 to 5768 296 to 1   fully sequenced,   296/296
(100 %)
0 diff
(100 %id)
R60953 whole brain .c 5484 to 5784 308 to 5       304/438
(69 %)
0 diff
(100 %id)
BE504842 pooled germ cell tumors .c 5490 to 5768 296 to 18   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 279/279
(100 %)
2 diff
(99.3 %id)
AI984732 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 5539 to 5775 237 to 1       237/237
(100 %)
0 diff
(100 %id)
AI671070 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 5559 to 5768 229 to 20   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 210/210
(100 %)
1 diff
(99.6 %id)
AA733213 heart .c 5594 to 5768 189 to 15   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 175/175
(100 %)
0 diff
(100 %id)
AW150432 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 5598 to 5774 177 to 1       177/177
(100 %)
1 diff
(99.5 %id)
EC470583 Prostate .c 5638 to 5766 131 to 4       128/131
(97 %)
0 diff
(100 %id)
FN060713 breast carcinoma .c 5643 to 5766 1 to 125       125/129
(96 %)
2 diff
(98.5 %id)
DB129992 thymus .d 1 to 572 2 to 573   tiling clone, capped   572/572
(100 %)
1 diff
(99.9 %id)
BP250372 hippocampus .d 82 to 663 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
BX484181   .d 97 to 582 1 to 486       486/486
(100 %)
1 diff
(99.8 %id)
DA178915 amygdala .d 146 to 716 2 to 572   tiling clone, capped   571/571
(100 %)
2 diff
(99.7 %id)
AI128825 heart .d 488 to 955 474 to 7   tiling clone,   468/474
(98 %)
0 diff
(100 %id)
AI634029 Kidney .d 559 to 954 396 to 1       396/396
(100 %)
1 diff
(99.8 %id)
BQ271444 Pancreas, Purified pancreatic islet .e 1 to 559 1 to 559   tiling clone,   559/559
(100 %)
3 diff
(99.5 %id)
AK308610 cerebellum .e 484 to 1987 1 to 1504 exact tiling clone,   1504/1504
(100 %)
1 diff
(100.0 %id)
DA098128 cerebellum .e 485 to 1045 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA835643 placenta .f 1 to 548 4 to 551   tiling clone, capped   550/550
(100 %)
0 diff
(100 %id)
AI701419 carcinoid, lung .f 381 to 1043 669 to 8   tiling clone,   662/670
(98 %)
2 diff
(99.8 %id)
BE467984 carcinoid, lung .f 386 to 1043 666 to 8       659/666
(98 %)
6 diff
(99.1 %id)
BE504282 carcinoid, lung .f 506 to 1043 545 to 8       538/545
(98 %)
1 diff
(99.9 %id)
DB128329 thymus .g 1 to 567 6 to 572 exact tiling clone, capped   571/571
(100 %)
0 diff
(100 %id)
DA632718 Kidney .h 1 to 240 2 to 241   tiling clone, capped   240/465
(51 %)
1 diff
(99.8 %id)
DN994101 brain, whole brain .h 58 to 485 9 to 435 exact tiling clone,   427/435
(98 %)
7 diff
(98.4 %id)
DA850840 placenta .i 1 to 540 2 to 541   tiling clone, capped   540/540
(100 %)
1 diff
(99.9 %id)
BQ271147 Pancreas, Purified pancreatic islet .i 451 to 1020 570 to 1   tiling clone,   570/570
(100 %)
0 diff
(100 %id)
CK825508 Pancreas, Purified pancreatic islet .i 628 to 981 354 to 1     Submitted on the opposite strand 354/354
(100 %)
0 diff
(100 %id)
BP375509 uterus .j 1 to 578 5 to 581   tiling clone,   581/581
(100 %)
2 diff
(99.7 %id)
DB007582 cervix, tumor tissue .j 1 to 558 4 to 561   capped   560/560
(100 %)
4 diff
(99.3 %id)
DA441424 tongue, tumor tissue .j 1 to 581 2 to 582   tiling clone, capped   581/581
(100 %)
3 diff
(99.5 %id)
DB149682 thymus .j 3 to 544 2 to 543   capped   542/542
(100 %)
1 diff
(99.9 %id)
BC068061 Skin, melanoma, melanotic .k 1 to 537 1 to 537 exact available from MGC, AAA   537/537
(100 %)
0 diff
(100 %id)
BC051238 Skin, melanoma, melanotic .k 1 to 537 1 to 537 exact tiling clone, available from MGC, AAA   537/537
(100 %)
0 diff
(100 %id)
BQ679149 melanotic melanoma, cell line, skin .k 2 to 537 1 to 536 exact AAA   536/536
(100 %)
0 diff
(100 %id)
BU155886 melanotic melanoma, cell line, skin .k 2 to 537 1 to 535 N9I L10S G11A G12A G13A ... available from MGC, AAA   535/535
(100 %)
2 diff
(99.7 %id)
BU191430 melanotic melanoma, cell line, skin .k 2 to 535 1 to 534 exact available from MGC,   534/1016
(52 %)
3 diff
(99.8 %id)
BF326318 amnion_normal .l-u 1 to 194 195 to 2   tiling clone,   194/204
(95 %)
0 diff
(100 %id)
BI048652 testis_normal .l-u 8 to 321 311 to 1 A18X D55E A56S tiling clone,   311/313
(99 %)
5 diff
(98.5 %id)
AW994279 breast_normal Gene SGPL1, variant not shown         Suspected internal deletion, this clone was ignored    
DA542952   Gene SGPL1, variant not shown       capped Suspected internal deletion, this clone was ignored    
AI636758 pooled germ cell tumors Gene SGPL1, variant not shown         This clone was ignored    
AI611104 pooled germ cell tumors Gene SGPL1, variant not shown         This clone was ignored    
AI672563 pooled germ cell tumors Gene SGPL1, variant not shown         This clone was ignored    
AI825499 pooled germ cell tumors Gene SGPL1, variant not shown         Suspected internal deletion, this clone was ignored    
BF508207   Gene SGPL1, variant not shown       AAA This clone was ignored    
BE999972 colon, colon tumor, RER+ Gene SGPL1, variant not shown         Suspected internal deletion, this clone was ignored    
TI_149299607   Gene SGPL1, variant not shown       AAA Suspected internal deletion, suspected internal deletion, this clone was ignored    
BM975917 lung, Primary Lung Cystic Fibrosis EpithelialCells Gene SGPL1, variant not shown       AAA Suspected internal deletion, suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC